Adora Ndu
Director/Board Member bij DBV TECHNOLOGIES
Vermogen: 83 628 $ op 31-03-2024
Actieve functies van Adora Ndu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DBV TECHNOLOGIES | Director/Board Member | 19-05-2021 | - |
Independent Dir/Board Member | 19-05-2021 | - | |
BRIDGEBIO PHARMA, INC. | General Counsel | 01-01-2022 | - |
ACADIA PHARMACEUTICALS INC. | Director/Board Member | 10-10-2022 | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | - | - |
Loopbaan van Adora Ndu
Eerdere bekende functies van Adora Ndu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIOMARIN PHARMACEUTICAL INC. | Director/Board Member | 01-02-2017 | 01-08-2019 |
Chief Tech/Sci/R&D Officer | 01-01-2021 | 01-01-2022 | |
General Counsel | 01-08-2019 | 01-01-2021 | |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Corporate Officer/Principal | 01-01-2008 | 01-01-2016 |
Opleiding van Adora Ndu
The University of Maryland Francis King Carey School of Law | Graduate Degree |
Howard University College of Medicine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Frankrijk | 2 |
Operationeel
Director/Board Member | 4 |
General Counsel | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
DBV TECHNOLOGIES | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |